{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:43:37Z","timestamp":1777484617989,"version":"3.51.4"},"reference-count":64,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer is one of the most common cancers in the world, with about one million cases diagnosed annually. Various treatment methods can be used to treat colorectal cancer, including chemotherapy with different drug regimens. Considering the need to opt for more effective and less expensive drugs in the treatment of this disease, the present study aimed to compare the cost-effectiveness of FOLFOX6+Bevacizumab with FOLFOX6+Cetuximab in patients with stage IV colorectal cancer referred to medical centers in Shiraz, Iran, in 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Using a decision tree, the cost-effectiveness and cost-utility of the 2 drug regimens were compared in all studied patients through the census method. Having a societal perspective, this study considered direct medical costs, direct non-medical costs, and indirect costs. The effectiveness indicators included the rate of major response to the drug combination used and the Quality-adjusted Life Year (QALY). The data were analyzed using Treeage 2011 and Excel 2016 software. In order to ensure the robustness of the results, one-way and probabilistic sensitivity analyses were performed as well.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results showed that the expected costs, the effectiveness (major response rate), and the QALYs of the FOLFOX6+Bevacizumab drug regimen were $16746.13(USD), .49, and .19, respectively, and those of the FOLFOX6+Cetuximab regimen were, respectively, $15191.05 (USD), .68, and .22. Therefore, FOLFOX6+Cetuximab compared to FOLFOX6+Bevacizumab was less costly and more effective and had a greater QALY, thus being considered as the dominant option. Also, the results of the sensitivity analyses showed that there was a bit of uncertainty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Considering that the FOLFOX6+Cetuximab regimen was more cost-effective, it is suggested to be prioritized in preparing clinical guidelines for Iranian colorectal cancer patients. In addition, increasing the basic and supplementary insurance coverage for this drug combination as well as the use of remote technology to guide patients by oncologists can be solutions to reduce direct and indirect costs of the patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748231180679","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T11:10:00Z","timestamp":1686741000000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran"],"prefix":"10.1177","volume":"30","author":[{"given":"Abdosaleh","family":"Jafari","sequence":"first","affiliation":[{"name":"Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedighe Sadat","family":"Tabatabaei Far","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Dehghani","sequence":"additional","affiliation":[{"name":"Department of Hematology and Medical Oncology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-9850","authenticated-orcid":false,"given":"Ramin","family":"Ravangard","sequence":"additional","affiliation":[{"name":"Health Human Resources Research Centre, School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"bibr1-10732748231180679","doi-asserted-by":"publisher","DOI":"10.5301\/grhta.5000274"},{"key":"bibr2-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17386-z"},{"issue":"10","key":"bibr3-10732748231180679","first-page":"1","volume":"5","author":"Mehrzad V","year":"2014","journal-title":"Adv Biomed Res"},{"key":"bibr4-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"bibr5-10732748231180679","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.24453"},{"key":"bibr6-10732748231180679","volume-title":"Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2020","author":"International Agency for Research on Cancer","year":"2020"},{"issue":"4","key":"bibr7-10732748231180679","first-page":"16","volume":"23","author":"Pourhoseingholi MA","year":"2014","journal-title":"Medical Science Journal of Islamic Azad University Tehran Medical Branch"},{"key":"bibr8-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2010.06.004"},{"key":"bibr9-10732748231180679","volume-title":"The MPOWER Package","author":"World Health Organization","year":"2008"},{"issue":"1","key":"bibr10-10732748231180679","first-page":"51","volume":"16","author":"Mahmoudvand H","year":"2014","journal-title":"Yafte"},{"key":"bibr11-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4465"},{"key":"bibr12-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i8.1993"},{"key":"bibr13-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3747\/co.26.4217"},{"key":"bibr14-10732748231180679","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2018.94.4.196"},{"key":"bibr15-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2007-0201"},{"key":"bibr16-10732748231180679","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20190114"},{"key":"bibr17-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2020.1717500"},{"key":"bibr18-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211009952"},{"issue":"1","key":"bibr19-10732748231180679","first-page":"39","volume":"11","author":"Bazyar M","year":"2012","journal-title":"Journal of Hospital"},{"issue":"1","key":"bibr20-10732748231180679","first-page":"1","volume":"2","author":"Amani F","year":"2012","journal-title":"Fekrat"},{"issue":"6","key":"bibr21-10732748231180679","first-page":"629","volume":"14","author":"Bahmei J","year":"2015","journal-title":"Health Monitor Journal of the Iranian Institute for Health Sciences Research"},{"key":"bibr22-10732748231180679","volume-title":"Methods for the economic evaluation of health care programmes","author":"Drummond MF","year":"2015","edition":"4"},{"key":"bibr23-10732748231180679","volume-title":"Health economics","author":"Karimi I","year":"2005","edition":"1"},{"key":"bibr24-10732748231180679","volume-title":"Economic evaluation","author":"Fox-Rushby J","year":"2005","edition":"2"},{"key":"bibr25-10732748231180679","doi-asserted-by":"publisher","DOI":"10.31925\/farmacia.2022.1.24"},{"key":"bibr26-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1105230"},{"key":"bibr27-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2016.07.002"},{"key":"bibr28-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-018-3158-8"},{"key":"bibr29-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092118"},{"key":"bibr30-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5481-z"},{"key":"bibr31-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-017-0027-6"},{"issue":"64","key":"bibr32-10732748231180679","first-page":"30","volume":"16","author":"Razavi SM","year":"2009","journal-title":"Razi J Med Sci"},{"key":"bibr33-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.08.008"},{"key":"bibr34-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1709848"},{"key":"bibr35-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820902271"},{"key":"bibr36-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.04.010"},{"key":"bibr37-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1837"},{"key":"bibr38-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.17-00159"},{"key":"bibr39-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.16.2938"},{"key":"bibr40-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.17012"},{"key":"bibr41-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9650-4"},{"key":"bibr42-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1422"},{"key":"bibr43-10732748231180679","volume-title":"Salary and benefit in 1400","author":"Talent I","year":"2021"},{"key":"bibr44-10732748231180679","unstructured":"Rates Today M. US Dollar to Iranian Rial Exchange Rate History; 2021:2021. https:\/\/fa.moneyratestoday.com\/mbadlh-nrkh-tarykh-dlar-amryka-bh-ryal-ayran.html?date=2021"},{"key":"bibr45-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2127"},{"key":"bibr46-10732748231180679","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.21584"},{"key":"bibr47-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr350"},{"issue":"1","key":"bibr48-10732748231180679","first-page":"1","volume":"1","author":"Hutubessy R","year":"2003","journal-title":"C\/E"},{"key":"bibr49-10732748231180679","volume-title":"Gross Domestic Product (GDP) Per Capita from 1987 to 2027 2022","author":"Iran S"},{"key":"bibr50-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s002800051084"},{"key":"bibr51-10732748231180679","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.651299"},{"key":"bibr52-10732748231180679","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S219318"},{"key":"bibr53-10732748231180679","doi-asserted-by":"publisher","DOI":"10.14196\/mjiri.31.115"},{"key":"bibr54-10732748231180679","doi-asserted-by":"publisher","DOI":"10.31925\/farmacia.2020.3.25"},{"key":"bibr55-10732748231180679","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22471"},{"key":"bibr56-10732748231180679","volume-title":"Cost-Effectiveness Analysis of Bevacizumab in Comparison with Cetuximab in Treatment of Metastatic Colorectal Cancer in Iran","author":"Najafi G","year":"2018"},{"issue":"2","key":"bibr57-10732748231180679","first-page":"1","volume":"10","author":"Han YN","year":"2022","journal-title":"Healthcare (Basel, Switzerland)"},{"key":"bibr58-10732748231180679","first-page":"1","volume":"11","author":"Qiu C","year":"2021","journal-title":"Front Oncol"},{"key":"bibr59-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08690-y"},{"key":"bibr60-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-018-0322-1"},{"key":"bibr61-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-021-00560-4"},{"key":"bibr62-10732748231180679","doi-asserted-by":"publisher","DOI":"10.14312\/2052-4994.2013-5"},{"key":"bibr63-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-12-S1-P3"},{"key":"bibr64-10732748231180679","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2021.07.001"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748231180679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748231180679","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748231180679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:35Z","timestamp":1777386215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748231180679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":64,"alternative-id":["10.1177\/10732748231180679"],"URL":"https:\/\/doi.org\/10.1177\/10732748231180679","relation":{},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"10732748231180679"}}